Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MIMETAS
Oegstgeest / Leiden area, South Holland, Netherlandsmimetas.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Commercial
01
Overview
MIMETAS develops advanced human tissue and disease models using its OrganoPlate® organ-on-a-chip technology. The company’s platforms are used by major pharmaceutical companies to improve the predictivity of preclinical studies, reduce reliance on animal models, and accelerate the development of new therapies. No direct clinical results as it does not develop therapeutics itself.
- Therapeutic areas
- OncologyImmunologyOther
- Modalities
- Device (Organ-on-a-chip)Cell-based assay platform3D cell culture technology
- Industry
- Non-Drug Biotech
02
Partnerships
Galapagos (launching customer)Nearly all major pharmaceutical companies as customers or collaborators
Beyond the preview
Go deeper on MIMETAS.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MIMETAS.